Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Evans

Showing results (201-210 of 228) with videos related to

Pageof 23
Sort By:
The American Journal of Clinical Nutrition|May 29, 2019
Blueberries improve biomarkers of cardiometabolic function in participants with metabolic syndrome-results from a 6-month, double-blind, randomized controlled trialPeter J Curtis, Vera van der Velpen, Lindsey Berends, et al.
American Journal of Respiratory and Critical Care Medicine|December 17, 2015
AMP-activated Protein Kinase Deficiency Blocks the Hypoxic Ventilatory Response and Thus Precipitates Hypoventilation and ApneaAmira D Mahmoud, Sophronia Lewis, Lara Juričić, et al.
BMC Endocrine Disorders|December 15, 2012
Comparison of Optimised MDI versus Pumps with or without Sensors in Severe Hypoglycaemia (the Hypo COMPaSS trial)Stuart Little, Thomas Chadwick, Pratik Choudhary, et al.
BMJ Open|July 15, 2021
Flash glucose monitoring with the FreeStyle Libre 2 compared with self-monitoring of blood glucose in suboptimally controlled type 1 diabetes: the FLASH-UK randomised controlled trial protocolEmma G Wilmot, Mark Evans, Katharine Barnard-Kelly, et al.
Nano Letters|May 22, 2014
Reusable, robust, and accurate laser-generated photonic nanosensorAli K Yetisen, Yunuen Montelongo, Fernando da Cruz Vasconcellos, et al.
JCI Insight|October 5, 2018
The DILfrequency study is an adaptive trial to identify optimal IL-2 dosing in patients with type 1 diabetesEleonora Seelig, James Howlett, Linsey Porter, et al.
JMIR Diabetes|September 29, 2023
Assessing the Content Validity, Acceptability, and Feasibility of the Hypo-METRICS App: Survey and Interview StudyUffe Søholm, Natalie Zaremba, Melanie Broadley, et al.
Scientific Reports|July 2, 2025
Exenatide and glucagon co-infusion increases myocardial glucose uptake and improves markers of diastolic dysfunction in adults with type 2 diabetesJames Goodman, Martin Schain, Giovanni Di Stefano, et al.
BMJ Open|April 15, 2025
Impact of real-time glucose monitoring using FreeStyle Libre 3 on glycaemia in type 2 diabetes managed with basal insulin plus SGLT2 inhibitor and/or GLP-1 agonist: the FreeDM2 randomised controlled trial protocolEmma G Wilmot, Ramzi A Ajjan, Yee S Cheah, et al.
Nature|April 24, 2009
NAADP mobilizes calcium from acidic organelles through two-pore channelsPeter J Calcraft, Margarida Ruas, Zui Pan, et al.
Pageof 23

Showing results (201-210 of 228) with videos related to

Sort By:
Pageof 23
The American Journal of Clinical Nutrition|May 29, 2019
Blueberries improve biomarkers of cardiometabolic function in participants with metabolic syndrome-results from a 6-month, double-blind, randomized controlled trialPeter J Curtis, Vera van der Velpen, Lindsey Berends, et al.
American Journal of Respiratory and Critical Care Medicine|December 17, 2015
AMP-activated Protein Kinase Deficiency Blocks the Hypoxic Ventilatory Response and Thus Precipitates Hypoventilation and ApneaAmira D Mahmoud, Sophronia Lewis, Lara Juričić, et al.
BMC Endocrine Disorders|December 15, 2012
Comparison of Optimised MDI versus Pumps with or without Sensors in Severe Hypoglycaemia (the Hypo COMPaSS trial)Stuart Little, Thomas Chadwick, Pratik Choudhary, et al.
BMJ Open|July 15, 2021
Flash glucose monitoring with the FreeStyle Libre 2 compared with self-monitoring of blood glucose in suboptimally controlled type 1 diabetes: the FLASH-UK randomised controlled trial protocolEmma G Wilmot, Mark Evans, Katharine Barnard-Kelly, et al.
Nano Letters|May 22, 2014
Reusable, robust, and accurate laser-generated photonic nanosensorAli K Yetisen, Yunuen Montelongo, Fernando da Cruz Vasconcellos, et al.
JCI Insight|October 5, 2018
The DILfrequency study is an adaptive trial to identify optimal IL-2 dosing in patients with type 1 diabetesEleonora Seelig, James Howlett, Linsey Porter, et al.
JMIR Diabetes|September 29, 2023
Assessing the Content Validity, Acceptability, and Feasibility of the Hypo-METRICS App: Survey and Interview StudyUffe Søholm, Natalie Zaremba, Melanie Broadley, et al.
Scientific Reports|July 2, 2025
Exenatide and glucagon co-infusion increases myocardial glucose uptake and improves markers of diastolic dysfunction in adults with type 2 diabetesJames Goodman, Martin Schain, Giovanni Di Stefano, et al.
BMJ Open|April 15, 2025
Impact of real-time glucose monitoring using FreeStyle Libre 3 on glycaemia in type 2 diabetes managed with basal insulin plus SGLT2 inhibitor and/or GLP-1 agonist: the FreeDM2 randomised controlled trial protocolEmma G Wilmot, Ramzi A Ajjan, Yee S Cheah, et al.
Nature|April 24, 2009
NAADP mobilizes calcium from acidic organelles through two-pore channelsPeter J Calcraft, Margarida Ruas, Zui Pan, et al.
Pageof 23